Vicente A, Estrada J, de la Cuerda C, Astigarraga B, Marazuela M, Blanco C, Lucas T, Barceló B
Department of Endocrinology, Universidad Autónoma, Madrid, Spain.
Acta Endocrinol (Copenh). 1991 Nov;125(5):470-4. doi: 10.1530/acta.0.1250470.
Fourteen adult patients (10 females and 4 males; age range 20-60 years) with persistent Cushing's disease after transsphenoidal microsurgery were treated with pituitary irradiation. Supervoltage multiportal administration was employed at a total dose of 50 Gy (+/- 0.65 SD). The interval between microsurgery and pituitary irradiation was less than 6 months in 6 patients and more than 6 months in 8. The pituitary-adrenal axis was evaluated postsurgically, before irradiation and every 6 months thereafter. The remaining anterior pituitary function was simultaneously tested. Remission rates at 12 months and 24 months after radiotherapy were 61 and 70%, respectively. Two patients developed TSH deficiency and another gonadotropin deficiency during the follow-up after radiation. We conclude that pituitary irradiation is the treatment of choice for persistent Cushing's disease after unsuccessful surgery because of its high efficiency and low incidence of adverse reactions when compared with other forms of treatment.
14例经蝶窦显微手术后仍患有持续性库欣病的成年患者(10例女性,4例男性;年龄范围20 - 60岁)接受了垂体放疗。采用超高压多野照射,总剂量为50 Gy(±0.65标准差)。6例患者显微手术与垂体放疗的间隔时间小于6个月,8例患者间隔时间大于6个月。术后、放疗前及放疗后每6个月评估垂体 - 肾上腺轴。同时检测剩余的垂体前叶功能。放疗后12个月和24个月的缓解率分别为61%和70%。2例患者在放疗后的随访期间出现促甲状腺激素缺乏,另1例出现促性腺激素缺乏。我们得出结论,与其他治疗方式相比,垂体放疗因其高效性和低不良反应发生率,是手术失败后持续性库欣病的首选治疗方法。